Healthtech Public Comp Sheet and Valuation Guide

Fill out the form to download a preview of this report. The full report is available through the PitchBook Platform.

Direct-to-consumer digital health companies are underperforming

Consumer-facing digital health companies continue to face challenges, underscored by their poor performance relative to the greater stock market in Q4 2024. Among healthtech companies, these virtual care & remote patient monitoring businesses were hit the hardest last quarter, while electronic health record & clinical information companies had a strong 2024 overall and outperformed major indexes.

For key publicly traded companies, our Q4 2024 Healthtech Public Comp Sheet and Valuation Guide tracks stock performance, changes in valuation, historical valuations, revenue growth, EBITDA growth, and EBITDA margins.